𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prediction of Crohn’s disease relapse with faecal calprotectin in infliximab responders: a prospective study

✍ Scribed by D. Laharie; S. Mesli; F. El Hajbi; E. Chabrun; E. Chanteloup; M. Capdepont; S. Razaire; V. de Lédinghen; F. Zerbib

Book ID
108606362
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
170 KB
Volume
34
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined approach with infliximab, surge
Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: Results from a prospective study
✍ Pauline Roumeguère; Dominique Bouchard; François Pigot; Alain Castinel; Frederic 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Background: Infliximab is the only medical therapy that has been proven to be effective in fistulizing Crohn's disease (CD), but the recurrence rate of fistulas is high despite maintenance therapy. The aim of this prospective study was to evaluate the short-and long-term efficacy of a combined sched

Long-term outcome of treatment with infl
Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: A population-based study
✍ Valérie Crombé; Julia Salleron; Guillaume Savoye; Jean-Louis Dupas; Gwénola Vern 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Background: We examined short-and long-term benefits and safety of infliximab (IFX) in a population-based cohort of Crohn's disease (CD) patients <17 years old at diagnosis. ## Methods: The following parameters were assessed: short-and long-term efficacy of IFX, impact of drug efficacy, and mode